Open Access

Socio–economic costs of migraine

  • Rosanna Cerbo1Email author,
  • Marina Pesare1,
  • Cinzia Aurilia1,
  • Valeria Rondelli1 and
  • Piero Barbanti1
The Journal of Headache and PainOfficial Journal of the Italian Society for the Study of Headaches and the Italian Society of Pain Clinicians2:3

DOI: 10.1007/s101940170003


Migraine is one of the most common neurological diseases afflicting 12% of general population but is poorly recognized and largely untreated. Migraine is a disabling disease with very high social costs as it affects young individuals during their productive age. Quality of life in migraineurs is impaired. Furthermore, the economic burden of migraine, usually evaluated in terms of direct and indirect costs, is relevant and could be reduced by an early diagnosis and an appropriate treatment.

Key words

Pharmacoeconomics Migraine